Semaglutide GLP-1 injections help promote weight loss in patients struggling with type 2 diabetes and obesity
Because the FDA does not regulate the safety or effectiveness of compounded semaglutide, there is no way to know if it is as effective as FDA-approved semaglutide
Even at lower doses, GLP-1s carry risks of gastrointestinal issues, including nausea, constipation, and general abdominal discomfort
[DOI] [PubMed] [Google Scholar] 28.Bonora B.M., Avogaro A., Fadini G.P
Growing evidence indicates that the glucagon-like peptide-1 (GLP-1) system is involved in the neurobiology of addictive behaviors, and GLP-1 analogues may be used for the treatment of alcohol use disorder (AUD)
The medication's appetite-suppressing effects may also make it difficult to consume adequate protein and calories necessary for muscle maintenance and recovery from intensive resistance training